Fremanezumab in Children and Adolescents with Episodic Migraine

Andrew D. Hershey

Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati

Christina L. Szperka

Children’s Hospital of Philadelphia, Philadelphia

Piero Barbanti

Headache and Pain Unit, IRCCS San Raffaele, Rome

Patricia Pozo-Rosich

Headache Unit and Research Group, Vall d’Hebron Hospital and Research Institute, Universitat Autonoma de Barcelona, Barcelona

Petra Bittigau

Department of Pediatric Neurology, Children’s Hospital, Charité-Universitätsmedizin Berlin, Berlin

Steve Barash

Teva Branded Pharmaceutical Products R&D, West Chester, PA

Juline Bryson

Teva Branded Pharmaceutical Products R&D, West Chester, PA

Yoel Kessler

Teva Pharmaceutical Industries, Tel Aviv, Israel

Yael Carmeli Schwartz

Teva Pharmaceutical Industries, Tel Aviv, Israel

Verena Ramirez Campos

Teva Branded Pharmaceutical Products R&D, West Chester, PA

Xiaoping Ning

Teva Branded Pharmaceutical Products R&D, West Chester, PA